Article

Chronic Hyponatremia

Author(s):

The Doctor's Channel

Dr. Mitchell Rosner discusses chronic hyponatremia and treatments options for patients diagnosed with the condition.

Mitchell H. Rosner, MD, Associate Professor of Medicine, University of Virginia Health System, discusses the prevalent condition of chronic hyponatremia and the latest diagnostic and treatment options for patients.

References and Resources

Do C, Anpalahan M, Janus E. Caution is advised in the treatment of chronic hyponatremia. Intern Med J. 2008 Dec;38(12):929; author reply 930. No abstract available.

Source:

Related Videos
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
HCPLive Five at Maui Derm NP+PA Fall 2024 | Image Credit: HCPLive
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
Steve Nissen, MD | Credit: Cleveland Clinic
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
Related Content
Antonio Anzueto, MD | Credit: UT Health San Antonio
October 14th 2024

The Potential Role of Dupilumab in COPD Management, with Antonio Anzueto, MD

Patrick Campbell
Brian Hansen | Credit: Ascensia Diabetes Care
October 15th 2024

Diabetes Dialogue: What to Know About the Eversense 365 CGM, with Brian Hansen

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Alnylam Submits sNDA for Vutrisiran for Treatment of ATTR-CM | Image Credit: US Food and Drug Administration
October 11th 2024

Alnylam Submits sNDA for Vutrisiran for Treatment of ATTR-CM

Connor Iapoce
Taher Modarressi, MD | Credit: X.com
October 3rd 2024

Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MD

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
AHN Welcomes New Physicians
October 9th 2024

AHN Welcomes New Physicians

Allegheny Health Network
US FDA LOGO IN BLACK OVER A WHITE BACKGROUND. | Credit: US Food and Drug Administration
October 8th 2024

FDA Issues Second CRL for Dasiglucagon (Zegalogue) in Congenital Hyperinsulinism

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.